1. |
García-Villarreal OA. Long-term effectiveness of the Cox-maze Ⅲ procedure and its relationship with left atrial postoperative size. Gaceta medica de Mexico, 2020, 155(6): 546-551.
|
2. |
Ruaengsri C, Schill MR, Khiabani AJ, et al. The Cox-maze Ⅳ procedure in its second decade: Still the gold standard? Eur J Cardiothorac Surg, 2018, 53(suppl_1): i19-i25.
|
3. |
Wolf RK, Schneeberger EW, Osterday R, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg, 2005, 130(3): 797-802.
|
4. |
Mei J, Ma N, Ding F, et al. Complete thoracoscopic ablation of the left atrium via the left chest for treatment of lone atrial fibrillation. J Thorac Cardiovasc Surg, 2014, 147(1): 242-246.
|
5. |
梅举, 姜兆磊, 刘兴鹏, 等. 微创外科-导管杂交消融术在长程持续性房颤治疗中的应用及疗效. 中华胸心血管外科杂志, 2018, 34(12): 724-728.
|
6. |
Henein MY, Mondillo S, Cameli M. Left atrial function. Anatol J Cardiol, 2019, 22(2): 52-53.
|
7. |
Ma N, Lu R, Zhao D, et al. Left atrial appendage fibrosis and 3-year clinical outcomes in atrial fibrillation after endoscopic ablation: A histologic analysis. Ann Thorac Surg, 2020, 109(1): 69-76.
|
8. |
Pilote L, Hunter I, Marpole D, et al. Stiff left atrial syndrome. Can J Cardiol, 1988, 4: 255-257.
|
9. |
Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythm, 2017, 33(5): 369-409.
|
10. |
Witt CM, Fenstad ER, Cha YM, et al. Increase in pulmonary arterial pressure after atrial fibrillation ablation: Incidence and associated findings. J Interv Card Electrophysiol, 2014, 40(1): 47-52.
|
11. |
Gibson DN, Di Biase L, Mohanty P, et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: Clinical characterization, prevalence, and predictors. Heart Rhythm, 2011, 8(9): 1364-1371.
|
12. |
Kisheva A, Yotov Y. Risk factors for recurrence of atrial fibrillation. Anatol J Cardiol, 2021, 25(5): 338-345.
|
13. |
Kranert M, Shchetynska-Marinova T, Liebe V, et al. Recurrence of atrial fibrillation in dependence of left atrial volume index. In Vivo, 2020, 34(2): 889-896.
|
14. |
Hwang J, Park HS, Han S, et al. The impact of catheter ablation of atrial fibrillation on the left atrial volume and function: Study using three-dimensional echocardiography. J Interv Card Electrophysiol, 2020, 57(1): 87-95.
|
15. |
Bytyçi I, D'Agostino A, Bajraktari G, et al. Left atrial stiffness predicts cardiac events in patients with heart failure and reduced ejection fraction: The impact of diabetes. Clin Physiol Funct Imaging, 2021, 41(2): 208-216.
|
16. |
Homan EA, Reyes MV, Hickey KT, et al. Clinical overview of obesity and diabetes mellitus as risk factors for atrial fibrillation and sudden cardiac death. Front Physiol, 2019, 9: 1847.
|
17. |
Ad N, Tian YY, Verbalis J, et al. The effect of the maze procedure on the secretion of arginine-vasopressin and aldosterone. J Thorac Cardiovasc Surg, 2003, 126(4): 1095-1100.
|
18. |
Wong GR, Lau DH, Baillie TJ, et al. Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation 'stiff left atrial syndrome'. Int J Cardiol, 2015, 181: 55-56.
|
19. |
Maeder MT, Nägele R, Rohner P, et al. Pulmonary hypertension in stiff left atrial syndrome: Pathogenesis and treatment in one. ESC Heart Fail, 2018, 5(1): 189-192.
|
20. |
Zaidi D, Williams D, Zhao D, et al. Interatrial stent to treat stiff left atrium syndrome. Cardiovasc Revasc Med, 2022, 40S: 337-340.
|